Cande Ananth, PhD, MPH, discusses a study exposing discrepancies in CDC maternal mortality data, highlighting errors in tracking methods and persistent racial disparities in maternal mortality rates.
In a recent interview, Cande Ananth, PhD, MPH, vice chair for Academic Affairs at Rutgers Robert Wood Johnson Medical School, discussed a study showcases changes in maternal mortality tracking methods.
The study evaluated US maternal mortality rates as reported by the Centers for Disease Control and Prevention (CDC). Currently, maternal mortality rates are high, with a steady increase observed over the past decade.
Investigators evaluated the causes of death and found that maternal death checkbox sent out by the CDC has been used erroneously in some cases. For example, almost 147 women aged 85 years or older with death linked to maternal mortality. This indicates errors caused by the introduction of the checkbox.
By using the “causes of death” fields rather than assessing mortality based on the checkbox, investigators found significantly reduced maternal mortality rates compared to those reported by the CDC. While the CDC is aware of these errors, the organization continued to spread this information from 2018 to 2022.
Notably, the research identified a disparity in mortality rates between Black and White women even when discounting the checkbox. Maternal mortality is increased 3-fold to 4-fold among Black women when compared to White women, indicating a significant disparity that has remained persistent over time.
Individual states should come together when evaluating data for the CDC, according to Ananth. Overall, clinicians have adapted this data into their practice, making it valuable to report.
Ananth stated that every loss is insurmountable, but clinicians have worked to reduce rates of not only maternal mortality, but also serious maternal morbidity. While rates are lower than the CDC estimates, doctors should continue this work to reduce the rates even further.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
Improved maternal cardiac arrest management reported from Obstetric Life Support training
November 19th 2024A study found that Obstetric Life Support education significantly improves health care providers' readiness and outcomes in maternal cardiac arrest management, advocating for broader implementation.
Read More